Back

Prognostic significance of diabetes mellitus in patients with atrial fibrillation

25 April 2021 (16:15 - 17:10)
Organised by:
Congress Presentation Part of: Pathophysiology of atrial fibrillation and beyond I Pathophysiology and Mechanisms, Other EHRA Premium Access EHRA 2021

About the speaker

Photo
Doctor Andreas Papazoglou

Naval Hospital of Athens, Athens (Greece)

5 More presentations in this session

Presentation thumbnail
Identification of novel biomarkers for predicting atrial fibrillation outcomes in patients with cardiovascular risk factors
Miss A. Khashaba (Birmingham, GB)
Abstract Slides Video
Presentation thumbnail
Impact of atrial fibrillation pattern on left atrial appendage closure: insights from the prospective LAARGE registry
Doctor S. Kany (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Sacubitril/valsartan therapy and supraventricular arrhythmias detected through remote monitoring in heart failure patients
Associate Professor F. Guerra (Ancona, IT)
Abstract Slides Video
Presentation thumbnail
RNA-seq profiling of the atrial transcriptome reveals gender-specific patterns and interactions with atrial fibrillation and heart failure
Mr D. Balamurali (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Impaired left atrial reservoir and conduit strain in patients with atrial fibrillation and extensive fibrosis
Mr L. Hopman (Amsterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysiology of atrial fibrillation and beyond I

The Event

Event poster

EHRA 2021

25 April 2021 16:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources